"FDA Investigates Ozempic for Potential Hair Loss and Suicidal Thought Side Effects"
The FDA is investigating reports of serious side effects potentially linked to popular weight loss drugs, including Ozempic, Wegovy, Mounjaro, and Zepbound. These side effects include hair loss (alopecia), aspiration during surgery, and suicidal ideation. While some side effects have led to updates in drug labels and calls for further study, the FDA has not yet confirmed a causal relationship between these medications and the reported issues. The European Medicines Agency is also reviewing the risk of suicidal thoughts associated with these drugs. The FDA's postmarketing surveillance aims to ensure drug safety throughout their lifecycle.